ID   4405P
AC   CVCL_WM23
DR   cancercelllines; CVCL_WM23
DR   Cosmic; 852199
DR   Wikidata; Q93306974
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Head, skin; UBERON=UBERON_0001084.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=15195137; DOI=10.1038/sj.onc.1207780;
RA   Daniotti M., Oggionni M., Ranzani T., Vallacchi V., Campi V.,
RA   Di Stasi D., Della Torre G., Perrone F., Luoni C., Suardi S.,
RA   Frattini M., Pilotti S., Anichini A., Tragni G., Parmiani G.,
RA   Pierotti M.A., Rodolfo M.;
RT   "BRAF alterations are associated with complex mutational profiles in
RT   malignant melanoma.";
RL   Oncogene 23:5968-5977(2004).
//